Login  /  Register  | 3 premium articles left before you must register.

Pfizer painkiller gets longer patent protection

Associated Press

Publication: theday.com

Published March 05. 2013 3:00PM   Updated March 05. 2013 3:05PM

NEW YORK (AP) _ Drugmaker Pfizer Inc. says a new patent on one of its top drugs, anti-inflammatory painkiller Celebrex, extends its U.S. patent protection by 18 months, potentially bringing the company a few billion dollars in additional revenue.

Shares of New York-based Pfizer jumped nearly 2 percent on news of the patent ruling. Pfizer also said it's suing several generic drugmakers to try to prevent them from selling generic versions of Celebrex before the new patent runs out.

Pfizer says the U.S. Patent & Trademark Office has granted what's called a "reissue patent." It covers methods of treating arthritis and other conditions with the drug's active ingredient, celecoxib. The new patent won't expire until Dec. 2, 2015, about 18 months after the basic patent for Celebrex expires on May 30, 2014.

News by Town

Most Recent Poll
The New York Times reports that corporate profits are experiencing a golden age, as high unemployment means companies do more with fewer people and don't have to offer raises. What do you think?
I think this is just a sign of trickle-down economics. Hiring will pick up, then wages.
12%
I think the gulf between company profits and employee earnings will only continue to widen.
33%
I'm still unemployed and willing to work at just about any wage.
3%
Um, exactly when hasn't it been a golden age for corporate America at the expense of workers?
52%
Number of votes: 1183

No current items found